Clinical Trial Update: Efficacy of NicVAX in Smokers Who Want to Quit Smoking [Phase 2]

View source ↗

Summary

Phase 2 trial update evaluating NicVAX, a nicotine vaccine, for smoking cessation; the study has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Nicotine Dependence

Drugs mentioned

• NicVAX (nicotine vaccine)

Snippet

Sponsor: National Institute on Drug Abuse (NIDA) | Conditions: Smoking Cessation | Phase 2 | Status: COMPLETED